Newborn Screening for Spinal Muscular Atrophy

National Taiwan University Hospital120,267 enrolled

Overview

To test if the routine newborn screening dried blood spots can be used to test if missing 2 copies of SMN1 gene, a status indicating spinal muscular atrophy

Parents of newborns will be invited to test if their newborns are affected with SMA. The routine newborn screening dried blood spots sample will be used to test if missing 2 copies of SMN1 gene. If positive of screening test, further confirmation tests including physical examination and other methology for SMN1 gene copies quantification will be provided. Genetic counseling and treatment option will be provided, too.

Study Type

OBSERVATIONAL

Enrollment

120,267

Conditions

Spinal Muscular Atrophy

Interventions

newborn screening test for SMAOTHER

Routine newborn screening dried blood spots sample is used to test if missing 2 copies of SMN1 gene.

Eligibility

Sex: ALLMin age: 2 DaysMax age: 3 MonthsHealthy volunteers:

Medical Language ↔ Plain English

Inclusion Criteria: * Babies born in Taiwan receive regular new born screening suggested by Ministry of Heath and Welfare. * Parents or Legal Guardian sign in the informed consent form. Exclusion Criteria: * Parents or Legal Guardian do not agree to sign in the informed consent form.

Locations (1)

National Taiwan University Hospital

Taipei, Taiwan, Taiwan

Outcomes

Primary Outcomes

numbers of newborn with spinal muscular atrophy

Time frame: 18 months

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.